Cynomolgus Recombinant Protein
CAT#: TP724822
Recombinant Cynomolgus B7-1/CD80 (C-His)
Need it in bulk or customized? Get a free quote |
CNY 3,140.00
货期*
5周
规格
Product images
Specifications
Product Data | |
Species | Cynomolgus |
Protein Source | Human 293 |
Expression cDNA Clone or AA Sequence |
Val35-Asn242
|
Tag | C-6His |
Buffer | Lyophilized from a 0.2 um filtered solution of PBS, 5% Trehalose pH 7.4 |
Note | Recombinant Cynomolgus T-lymphocyte Activation Antigen CD80 is produced by our Mammalian expression system and the target gene encoding Val35-Asn242 is expressed with a 6His tag at the C-terminus. |
Storage | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-5 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
Stability | 12 months from date of despatch |
Reference Data | |
Synonyms | T-lymphocyte activation antigen CD80; Activation B7-1 antigen; B7; CD80 |
Summary | CD80, also known as B7-1, is a member of cell surface immunoglobulin superfamily. CD80 is predominately expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. CD80 and CD86, together with their receptors CD28 and CTLA4, form one of the dominant co-stimulatory pathways that mediate T- and B- cell responses. Although both CD28 and CTLA4 can bind to CD80 and CD86, CTLA-4 has 20-100 fold higher affinity than CD28 plays a role in the down-regulation of the immune response. CD80 is also involved in the induction of innate immune responses by activating NF-κB-signaling pathway in macrophages. Therefore, CD80 has the potential to be promising therapeutic targets for autoimmune diseases and various carcinomas. |
Documents
FAQs |
SDS |
Customer
Reviews
Loading...